Trials / Completed
CompletedNCT00340327
Study Evaluating IMA-638 in Healthy Japanese
An Ascending Single Dose Study of the Safety and Pharmacokinetics of IMA-638 Administered to Healthy Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and drug levels for single, ascending doses of IMA-638 in healthy Japanese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IMA-638 |
Timeline
- Start date
- 2006-06-01
- Completion
- 2007-07-01
- First posted
- 2006-06-21
- Last updated
- 2007-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00340327. Inclusion in this directory is not an endorsement.